File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/0162-3109(96)00083-5
- Scopus: eid_2-s2.0-0030175762
- PMID: 8856114
- WOS: WOS:A1996VA29800008
- Find via
Supplementary
- Citations:
- Appears in Collections:
Conference Paper: Endothelium-derived hyperpolarizing factor: A key mediator of the vasodilator action of bradykinin
Title | Endothelium-derived hyperpolarizing factor: A key mediator of the vasodilator action of bradykinin |
---|---|
Authors | |
Keywords | epoxyeicosanoids K+ channels kinins nitric oxide prostaglandins |
Issue Date | 1996 |
Publisher | Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/immpharm |
Citation | Immunopharmacology, 1996, v. 33 n. 1-3, p. 46-50 How to Cite? |
Abstract | Bradykinin causes vasodilatation by stimulating the production of vasodilator prostanoids and nitric oxide (NO). However, there is an additional component that is mediated by a diffusible endothelium-derived hyperpolarizing factor (EDHF). The non-selective inhibitor of arachidonic acid metabolism eicosatetraenoic acid inhibits the EDHF-mediated component of the relaxation to bradykinin. Therefore, EDHF may be an arachidonic acid metabolite. The diffusible nature of EDHF has been disputed because of the inability to consistently detect the factor using perfusion bioassay techniques. However, administration of the acyltransferase inhibitor thimerosal facilitates the release of EDHF by endothelial cells in culture. Further studies are warranted to identify EDHF and explore further its functions in vasomotion. |
Persistent Identifier | http://hdl.handle.net/10722/173527 |
ISSN | |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Mombouli, JV | en_US |
dc.contributor.author | Bissiriou, I | en_US |
dc.contributor.author | Agboton, V | en_US |
dc.contributor.author | Vanhoutte, PM | en_US |
dc.date.accessioned | 2012-10-30T06:32:31Z | - |
dc.date.available | 2012-10-30T06:32:31Z | - |
dc.date.issued | 1996 | en_US |
dc.identifier.citation | Immunopharmacology, 1996, v. 33 n. 1-3, p. 46-50 | en_US |
dc.identifier.issn | 0162-3109 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/173527 | - |
dc.description.abstract | Bradykinin causes vasodilatation by stimulating the production of vasodilator prostanoids and nitric oxide (NO). However, there is an additional component that is mediated by a diffusible endothelium-derived hyperpolarizing factor (EDHF). The non-selective inhibitor of arachidonic acid metabolism eicosatetraenoic acid inhibits the EDHF-mediated component of the relaxation to bradykinin. Therefore, EDHF may be an arachidonic acid metabolite. The diffusible nature of EDHF has been disputed because of the inability to consistently detect the factor using perfusion bioassay techniques. However, administration of the acyltransferase inhibitor thimerosal facilitates the release of EDHF by endothelial cells in culture. Further studies are warranted to identify EDHF and explore further its functions in vasomotion. | en_US |
dc.language | eng | en_US |
dc.publisher | Elsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/immpharm | en_US |
dc.relation.ispartof | Immunopharmacology | en_US |
dc.subject | epoxyeicosanoids | - |
dc.subject | K+ channels | - |
dc.subject | kinins | - |
dc.subject | nitric oxide | - |
dc.subject | prostaglandins | - |
dc.subject.mesh | 5,8,11,14-Eicosatetraynoic Acid - Pharmacology | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Arachidonic Acid - Metabolism | en_US |
dc.subject.mesh | Biological Assay | en_US |
dc.subject.mesh | Biological Factors - Analysis - Physiology | en_US |
dc.subject.mesh | Bradykinin - Pharmacology - Physiology | en_US |
dc.subject.mesh | Electrophysiology | en_US |
dc.subject.mesh | Endothelium, Vascular - Drug Effects - Physiology | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Nitric Oxide - Physiology | en_US |
dc.subject.mesh | Receptor, Bradykinin B2 | en_US |
dc.subject.mesh | Receptors, Bradykinin - Physiology | en_US |
dc.subject.mesh | Vasodilation - Drug Effects - Physiology | en_US |
dc.title | Endothelium-derived hyperpolarizing factor: A key mediator of the vasodilator action of bradykinin | en_US |
dc.type | Conference_Paper | en_US |
dc.identifier.email | Vanhoutte, PM:vanhoutt@hku.hk | en_US |
dc.identifier.authority | Vanhoutte, PM=rp00238 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1016/0162-3109(96)00083-5 | en_US |
dc.identifier.pmid | 8856114 | - |
dc.identifier.scopus | eid_2-s2.0-0030175762 | en_US |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-0030175762&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 33 | en_US |
dc.identifier.issue | 1-3 | en_US |
dc.identifier.spage | 46 | en_US |
dc.identifier.epage | 50 | en_US |
dc.identifier.isi | WOS:A1996VA29800008 | - |
dc.publisher.place | Netherlands | en_US |
dc.identifier.scopusauthorid | Mombouli, JV=7004285772 | en_US |
dc.identifier.scopusauthorid | Bissiriou, I=8052855800 | en_US |
dc.identifier.scopusauthorid | Agboton, V=8052855900 | en_US |
dc.identifier.scopusauthorid | Vanhoutte, PM=7202304247 | en_US |
dc.identifier.issnl | 0162-3109 | - |